Using lagundi as herbal medicine for mild coronavirus disease (COVID-19) patients yielded positive results, the Department of Science and Technology (DOST) said. Lagundi (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&D) Rowena Cristina Guevara bared the initial...
The country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in isolation facilities will begin on Oct. 15, the Department of Science and Technology...
The clinical trial on the use of anti-parasitic drug Ivermectin for COVID-19 patients in the country has been moved again for one more month, from Sept. 15 to Oct. 15, due to ongoing revisions on its protocols. Department of Science and Technology (DOST) Sec. Fortunato Dela Peña said in a...
The Department of Science and Technology (DOST) has invested P8.4 million to determine the safety and efficacy of virgin coconut oil (VCO) as adjunctive therapy for coronavirus disease (COVID-19) patients, and to evaluate its beneficial effects for probable COVID-19 patients who are quarantined in...
The country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) is set to begin on Sept. 15, the Department of Science and Technology (DOST) said Friday, Aug. 27. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and...
The second and third phases of the clinical study on the safety and efficacy of the plant-based anti-dengue drug will start in September this year, and "will be completed within a year", the Department of Science and Technology (DOST) said on Friday, Aug. 20. (MANILA BULLETIN FILE PHOTO) DOST...
The Department of Science and Technology (DOST) said Thursday, Aug. 19, that the changes to clinical trial protocols have delayed the start of the country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) in the country....
The clinical trials on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) will begin next month, the Department of Science and Technology (DOST) said on Wednesday, Aug. 18. (MANILA BULLETIN FILE PHOTO) DOST Secretary Fortunato “Boy” T. de la Peña said the eight month-long...
The World Health Organization’s (WHO) Solidarity Vaccine Trial (SVT) in the country is being targeted to be conducted by August 15, the Department of Science and Technology (DOST) said Monday, July 26. (Photo by Ali Vicoy/MANILA BULLETIN) DOST Undersecretary for Research and Development Rowena...
The clinical trials on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) will start next month. (MANILA BULLETIN FILE PHOTO) The Department of Science and Technology- Philippine Council for Health Research and Development (DOST-PCHRD) said Friday, July 23, that the eight...
Only five patients are needed to be enrolled in a clinical trial on the effectiveness of virgin coconut oil (VCO) as an adjunct therapy for hospitalized coronavirus disease (COVID-19) patients, the Department of Science and Technology (DOST) said Friday, July 2. Virgin coconut oil (Manila Bulletin...
The Department of Science and Technology (DOST) expressed optimism that Lagundi (Chinese chaste tree) will soon be considered as a remedy to be used by patients with mild symptoms of coronavirus disease (COVID-19). Lagundi (FLICKR / MANILA BULLETIN / FILE PHOTO) During the Laging Handa public...
